Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
K Remes, P Anttila, R Silvennoinen, M Putkonen… - PloS one, 2018 - journals.plos.org
… Study objectives The objectives of this study are to investigate real-world MM treatment outcomes
in … challenges in using retrospective registry data in assessing these specific outcomes. …
in … challenges in using retrospective registry data in assessing these specific outcomes. …
EGFR mutation-positive lung cancer in real-world treatment outcomes: A multicenter study from Thailand
S Sukauichai, K Maneenil, A Supavavej… - Asian Pacific Journal of …, 2022 - waocp.com
… Results: This study included 284 patients with a median follow-up time of 19.8 months
and a death rate of 80.3%(228/284). Clinical characteristics included median age 62.5 years, …
and a death rate of 80.3%(228/284). Clinical characteristics included median age 62.5 years, …
Outcomes of endovascular thrombectomy in the elderly: a 'real-world'multicenter study
… We have confirmed, in this multicenter study, the rapid age-dependent increase in mortality
rate and rate of poor outcomes after ET in octogenarians. The reduced efficacy of ET in …
rate and rate of poor outcomes after ET in octogenarians. The reduced efficacy of ET in …
Real-world treatment outcomes of the EXTREME regimen as first-line therapy for recurrent/metastatic squamous cell carcinoma of the head and neck: a multi-center …
D Sano, T Fujisawa, M Tokuhisa, M Shimizu… - … research, 2019 - ar.iiarjournals.org
… In this study, we present the result of a multiple-center retrospective cohort study to
determine the real-world treatment outcomes of the EXTREME regimen as first-line therapy for …
determine the real-world treatment outcomes of the EXTREME regimen as first-line therapy for …
… world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter …
G Mele, A Melpignano, G Quarta, G Palumbo… - Leukemia Research, 2015 - Elsevier
… This current retrospective multicenter analysis represents, to our knowledge, the first Italian
… a retrospective multi-center series of 290 patients with refractory/relapsed MM treated with “…
… a retrospective multi-center series of 290 patients with refractory/relapsed MM treated with “…
[HTML][HTML] … and safety results of NABUCCO: real-world data from a noninterventional, prospective, multicenter study in 697 patients with metastatic breast cancer treated …
N Marschner, C Salat, U Söling, R Hansen… - Clinical Breast …, 2018 - Elsevier
… of this study per se limits comparability to other clinical trial data. In most cases safety issues
were manageable, and our results reflect acceptable tolerability of nab-P therapy. Grade 3/4 …
were manageable, and our results reflect acceptable tolerability of nab-P therapy. Grade 3/4 …
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world …
L Pizzuti, E Krasniqi, I Sperduti… - Therapeutic …, 2021 - journals.sagepub.com
… To address this issue and to provide a picture of the advancement of anti-HER2 treatments,
we performed a large, multicenter, retrospective study of HER2-positive BC patients. …
we performed a large, multicenter, retrospective study of HER2-positive BC patients. …
Real-world treatment patterns and clinical outcomes in EGFR-mutant unresectable locally advanced NSCLC (LA-NSCLC): A retrospective multicenter study of 367 …
N Bi, L Wang, K Xu, H Ge, ME, L Zhang, J Cao… - 2020 - ascopubs.org
9047 Background: The chemoradiation therapy (CRT) is the standard care for unresectable
LA-NSCLC. The addition of EGFR-TKIs in first-line treatment of EGFR-mutant subpopulation …
LA-NSCLC. The addition of EGFR-TKIs in first-line treatment of EGFR-mutant subpopulation …
Real-world treatment profiles, clinical outcomes, and healthcare resource utilization of patients with migraine prescribed erenumab: a multicenter chart-review study of …
… Therefore, this study aimed to characterize the real-world treatment profiles, clinical outcomes,
and healthcare resource utilization (HRU) of patients prescribed erenumab from select …
and healthcare resource utilization (HRU) of patients prescribed erenumab from select …
… ‐world clinical characteristics and treatment patterns of individuals aged 80 and older with Nonvalvular atrial fibrillation: results from the ReAl‐life Multicenter survey …
… ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey) study was to
report the real-world … from a large cohort of a nationwide survey on AF and to compare them …
report the real-world … from a large cohort of a nationwide survey on AF and to compare them …
相关搜索
- retrospective multicenter study real world outcome
- real world treatment outcomes multiple myeloma
- real world treatment outcomes lung cancer
- cohort study real world treatment patterns
- multicenter study real world data
- clinical outcomes real world treatment patterns
- clinical outcomes prospective real world study
- treatment outcome analysis multicentre observational study
- large patient cohort real world treatment
- treatment outcomes real world utilization
- real world outcomes in patients
- real world outcomes czech registry
- real world study egfr tkis
- egfr mutant real world treatment patterns
- lung adenocarcinoma real world treatment patterns
- real life multicenter survey clinical characteristics